A new study points to signs of weakness that began to show in the U.S. IPO boom last year, despite a 36 percent jump in new tech and life science offerings in 2014.
There was a sharp drop in tech offerings in the second half and the overwhelming majority of life science IPOs included a lot of insider buying, the report from the Fenwick & West law firm said.
"While 13 U.S.-based technology companies completed IPOs in the second half of 2014, this number was down nearly 50 percent from the 25 completed…Friday, March 20, 2015
New study points to cracks in recent IPO boom
A new study points to signs of weakness that began to show in the U.S. IPO boom last year, despite a 36 percent jump in new tech and life science offerings in 2014.
There was a sharp drop in tech offerings in the second half and the overwhelming majority of life science IPOs included a lot of insider buying, the report from the Fenwick & West law firm said.
"While 13 U.S.-based technology companies completed IPOs in the second half of 2014, this number was down nearly 50 percent from the 25 completed…
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment